The division of Pharmaceutical Technology comprises studies on formulation, manufacturing and delivery of drugs. A special emphasis is placed on formulation and manufacturing, with the GEA-NUS Pharmaceutical Processing Research Laboratory (GEA-NUS PPRL) as one of the most well-equipped academically-based centres on pharmaceutical solid formulation in Asia. Pharmaceutical solids include conventional tablets and capsules especially designed for (but not limited to) pulmonary delivery. Scientists in this domain are also involved in novel dosage forms such as hybrid nanoparticle composites and multi-functional constructs for tissue engineering and repair.
Among the most recent and impactful discoveries, this group has gained remarkable attention for:
- Combining innovative formulation science and advanced process technology from the academia to the pharmaceutical and allied industries in the region and the world
- Discovering the protective role of functionalized single walled carbon nanotubes in enhancing ex vivo expansion of hematopoietic stem and progenitor cells in human umbilical cord blood
- Establishing a selective and controlled release of Pt-based drugs from functionalized nanoparticles
- Developing novel hybrid PEG-peptide hydrogels with antimicrobial properties for stem cell delivery in cartilage repair
- Exploiting topical and transdermal drug delivery using hydrogels and organogels, as well as fabrication of hair constructs
- Innovations in formulation science to overcome delivery difficulties of therapeutic agents & to optimize health outcomes in special populations